CelLBxHealth plc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANPCY and other ETFs, options, and stocks.About ANPCY
CelLBxHealth Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood.
CEOPeter Collins
CEOPeter Collins
Employees119
Employees119
HeadquartersGuildford, Surrey
HeadquartersGuildford, Surrey
Founded2003
Founded2003
Employees119
Employees119
ANPCY Key Statistics
Market cap4.97M
Market cap4.97M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume18.17K
Average volume18.17K
High today$0.20
High today$0.20
Low today$0.11
Low today$0.11
Open price$0.11
Open price$0.11
Volume20.00K
Volume20.00K
52 Week high$2.39
52 Week high$2.39
52 Week low$0.11
52 Week low$0.11
Stock Snapshot
With a market cap of 4.97M, CelLBxHealth plc(ANPCY) trades at $0.15. The stock has a price-to-earnings ratio of -0.24.
On 2025-12-05, CelLBxHealth plc(ANPCY) stock moved within a range of $0.11 to $0.20. With shares now at $0.15, the stock is trading +40.0% above its intraday low and -23.0% below the session's peak.
Trading activity shows a volume of 20K, compared to an average daily volume of 18.17K.
Over the past 52 weeks, CelLBxHealth plc(ANPCY) stock has traded between a high of $2.39 and a low of $0.11.
Over the past 52 weeks, CelLBxHealth plc(ANPCY) stock has traded between a high of $2.39 and a low of $0.11.